2-pyrrolino-dox has been researched along with Adenocarcinoma Of Kidney in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, B; Engel, JB; Gaiser, T; Halmos, G; Keller, G; Nagy, A; Schally, AV | 1 |
Baker, B; Engel, JB; Halmos, G; Keller, G; Nagy, A; Schally, AV | 1 |
2 other study(ies) available for 2-pyrrolino-dox and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
Topics: Animals; Antineoplastic Agents; Binding Sites; Blotting, Western; Carcinoma, Renal Cell; Cell Differentiation; Cell Line, Tumor; DNA, Complementary; Doxorubicin; Humans; Immunohistochemistry; Kidney; Kidney Neoplasms; Kinetics; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Protein Binding; Pyrroles; Receptors, LHRH; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bombesin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Cell Transplantation; Chemokines, CC; Disease Models, Animal; Doxorubicin; Drug Resistance, Neoplasm; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Receptors, Bombesin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2005 |